Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report) traded down 7.2% during mid-day trading on Monday . The stock traded as low as $19.26 and last traded at $19.64. 73,528 shares traded hands during trading, a decline of 51% from the average session volume of 149,800 shares. The stock had previously closed at $21.17.
Ascentage Pharma Group International Trading Down 7.4 %
Ascentage Pharma Group International Company Profile
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Featured Articles
- Five stocks we like better than Ascentage Pharma Group International
- What does consumer price index measure?
- Finding Hidden Gems: Unconventional Penny Stock Investing
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Price Targets on NVIDIA Rise in Front of Earnings
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
